NIZBRO CAP
Packing: – 10X10
M.R.P: – 790
NIZBRO consists of Acebrophylline capsule is a medication used to treat and prevent asthma and chronic obstructive lung disease. Acebrophylline is a bronchodilator and a mucolytic. It works by relaxing the muscles of the airways as well as thinning and loosening mucus, making breathing easier.
It is a bronchodilator and mucolytic drug used to treat asthma and chronic obstructive lung disease symptoms (COPD). Acebrophylline is a mucolytic and bronchodilator that acts by relaxing the muscles of the airways as well as thinning and loosening mucus, making breathing easier. Acebrophylline includes ambroxol, which aids in several stages in the creation of pulmonary surfactant, as well as theophylline-7 acetic acid, whose carrier role elevates blood levels of ambroxol, thereby swiftly and intensively promoting surfactant formation.
Direction To Use This Medication
Acebrophylline Capsules may concern the patient since this may cause some side effects. However, if the patient experiences any kind of unusual side effects then let the doctor know.
These are some of the common side effects that will disappear once the body is adapted to the medicine.
Soigner Pharma, one of the major pharma businesses, has made an indelible impact on the industry. The firm is ISO accredited and works as per the norms set by WHO and GMP. Soigner Pharma is a well-known Acebrophylline Capsules manufacturer and supplier, as well as a provider of PCD Pharma Franchise for Acebrophylline Capsules. We provide exclusive rights and profitable services to franchise businesses. To balance the quantity and quality of the products, we make them in an efficient manufacturing lane.
ACEBROPHYLLINE HAS 3 ACTIONS NAMELY BRONCHODILATION, MUCOREGULATION & ANTI-INFLAMMATORY ACTION.
PHARMACOLOGY
A.)PHARMACODYNAMICS: Acebrophylline inhibits intracellular phosphodiesterase associated significantly reduce
airway inflammation and obstruction in chronic stages. Acebrophylline increases the synthesis and release of alveolar surfactant, resulting in triple action: mucoregulation, stimulation of bronchoalveolar clearance, and anti-inflammatory-interactive effect. In patients with chronic obstructive bronchitis, given the drug for 10-20 days, there was a good reduction in expectorating Viscosity. With cAMP levels and facilitates bronchial muscles relaxation. Acebrophylline selectively inhibits phosphatidylcholine and phospholipase A, TNF-alpha, and leukotrienes. Inhibition of such pro-inflammatory mediators can.
B.)PHARMACOKINETICS:
• Absorption: – 200mg oral acebrophylline, the two components of the molecule, ambroxol and theophylline-7-acetic acid are released in the stomach and absorbed in the intestine, reaching optimal concentrations of ambroxol within 2hrs and of theophylline-7-acetic acid after 1 hr.
• Half-Life: – The plasma half-life varies from 4 to 9 hrs after oral administration.
• Metabolism: – The drug is metabolized in the liver and eliminated renally.
Indications: Treatment of adult patients with COPD and bronchial asthma.
| Brand Name | NIZBRO CAP |
|---|---|
| Composition | (ACEBROPHYLLINE 100 MG CAP) |
| Pack Type | ALU-ALU |
| Pack Size | 10X10 |
No, you should not stop taking this medicine without consulting your doctor, as it may worsen your condition or cause symptoms to return. Take it for the full duration prescribed and consult your doctor if you face any issues.
No, breastfeeding mothers should avoid using this medicine unless advised by a doctor. It is not recommended during breastfeeding unless clearly necessary.
No, avoid alcohol while taking this medicine, as it may increase dizziness and drowsiness.
Yes, doctors may prescribe Acebrophylline along with antibiotics in case of a respiratory infection. Always follow your doctor’s advice.
Long-term use is generally safe when taken under medical supervision. Regular check-ups are important for managing chronic respiratory conditions.
I-BAR XT CAP
Send Enquiry
This will close in 0 seconds
This will close in 0 seconds
